3338 views | 5 years ago
We caught up with Anthony Philippakis, Chief Data Officer at The Broad Institute, and Susan Tousi, Senior Vice President of Product Development at Illumina, at the 2018 Bio-IT World Conference in Boston,...
7332 views | 5 years ago
It’s time to rethink NIPT. Introducing the VeriSeq NIPT solution, a powerful screening test from Illumina that can provide information on the health of a developing fetus using a simple maternal blood...
2365 views | 5 years ago
Dr. Martin Chavez, Chief of Maternal Fetal Medicine at Winthrop University Hospital discusses why he recommends noninvasive prenatal testing (NIPT). He notes that its accuracy, sensitivity, and specificity...
39138 views | 5 years ago
The VeriSeq™ NIPT solution from Illumina is a powerful screening test that provides the most comprehensive view of the fetal genome using a simple maternal blood draw. Cell-free DNA, released by placental...
11875 views | 5 years ago
The VeriSeq™ NIPT solution from Illumina is a powerful screening test that can provide information on the health of a developing fetus using a simple maternal blood draw. Cell-free DNA, released by...
2006 views | 5 years ago
If you think noninvasive prenatal testing (NIPT) is too complicated, think again. Discover VeriSeq NIPT, a different approach from Illumina. Built on industry-leading technology, the solution is simple,...
6184 views | 6 years ago
The increased ease of next-generation sequencing (NGS) means more data to interpret than ever before. The process for variant annotation, curation, and interpretation can be extremely cumbersome. The...
1852 views | 6 years ago
Accelerate your research with the AmpliSeq for Illumina solution—the new workflow for your targeted next-generation sequencing (NGS) studies. Quickly identify, annotate, and classify disease-relevant...